Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells

Journal of Cellular Physiology

Volumn 191, Issue 2, 2002, Pages 208-216

  Wilson, Michael J ^a,b   Sellers, Robert G ^c   Wiehr, Carol ^b   Melamud, Ori ^c   Pei, Duanqing ^d   Peehl, Donna M ^a,c  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE INHIBITOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL MEMBRANE PERMEABILITY; ENZYME RELEASE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; ZYMOGRAPHY;

CYCLOHEXIMIDE; DACTINOMYCIN; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HORMONES; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NUCLEIC ACID SYNTHESIS INHIBITORS; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; STROMAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0036205726     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10092     Document Type: Article

References (78)

1. TGF-β in prostate cancer: A growth inhibitor that can induce tumorigenicity
2. Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface
3. Matrix metalloproteinases: A review
4. Increased expression of the 72-kDa type IV collagenase in prostatic adenocarcinoma: Demonstration by immunohistochemistry and in situ hybridization
5. Regulation of matrix metalloproteinase-2 (gelatinase A, MMP-2), membrane-type matrix metalloproteinase-1 (MT1-MMP) and tissue inhibitor of metalloproteinases-2 (TIMP-2) expression by elastin-derived peptides n human HT-1080 fibrosarcoma cell line
6. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
7. Transforming growth factor-β induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: Abnormalities in cells cultured from benign prostatic hyperplasia tissues
8. Benign prostatic stromal cells are regulated by fibroblast growth factor and transforming growth factor β1
9. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostate tissues and cancer cell lines
10. Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metallproteinase- 1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells
11. Transforming growth factor β1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metabolizing cancer cells
12. Transforming growth factor-β1: Comparative immunohistochemical localization in human primary and metastatic prostate cancer
13. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor
14. Cellular strategies for proteolytic targeting during migration and invasion
15. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta
16. Transforming growth factor-β1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by upregulating urokinase activity
17. Osteoblast-derived TGF-β1 modulates matrix degrading protease expression and activity in prostate cancer cells
18. TGF-β1 expression in benign and malignant prostatic tumors
19. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-β
20. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
21. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecylsulfate and copolymerized substrates
22. Stromal cell expression of components of matrix-degrading protease systems in human cancer
23. Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostatic tissue: Analytical aspects
24. Regulation of prostatic stromal cell growth and function by transforming growth factor-beta (TGF-β)
25. Matrilysin expression in human prostate carcinoma
26. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate
27. Epilysin: A novel human matrix metalloproteinase (MMP-27) expressed in testis and keratinocytes and in response to injury
28. Secretion of matrix-metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: Reduced tissue inhibitor of metalloproteinase secretion by malignant tissues
29. Transforming growth factor-β1 stimulates glomerular mesangial cell synthesis of the 72-kDa type IV collagenase
30. Matrix metalloproteinases: Structures, evolution, and diversification
31. Matrix metalloproteinases: They're not just for matrix anymore!
32. Biology and biochemistry of proteinases in tumor invasion
33. Immunohistochemical evaluation of type IV collagenase (72-kDa metalloproteinase) in prostatic intraepithelial neoplasia
34. Increased expression of genes for basic fibroblast growth factor and transforming growth factor type β2 in human benign prostatic hyperplasia
35. Involvement of tissue inhibitors of metalloproteinases (TIMPS) during matrix metalloproteinase activation
36. Prostatic ductal system in rats: Tissue-specific expression and regional variation in stromal distribution of transforming growth factor-β1
37. Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer
38. Concanavalin A produces a matrixdegradative phenotype in human fibroblasts: Induction and endogenous activation of collagenase, 72-kDa gelatinase, and pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases
39. Independent regulation of collagenase, 72-kDa progelatinase, and metalloproteinase inhibitor expression in human fibroblasts by transforming growth factor-β
40. Expession of metalloproteinase genes in human prostate cancer
41. Protein, nucleotide identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor
42. Culture of human prostatic epithelial cells
43. Cellular biology of prostatic growth factors
44. Induction of smooth muscle phenotype in cultured human prostatic stromal cells
45. In vitro studies of human prostatic epithelial cells: Attempts to identify distinguishing features of malignant cells
46. Identification and characterization of the fifth member of the membrane-type matrix metalloproteinase MT5-MMP
47. CA-MMP: A matrix metalloproteinase with a novel cysteine-array, but without the classic cysteine switch
48. MMP25/MT6-MMP/Leukolysin: A novel matrix metalloproteinase specifically expressed in the leukocyte lineage
49. Immunohistochemical localization of TGF-β1, TGF-β2, and TGF-β3 in normal and malignant human prostate
50. Complex roles of matrix metalloproteinases in tumor progression
51. The effects of exogenous growth factors on matrix metalloprotease secretion by human brain tumour cells
52. Opposite effect of stable transfection of bioactive transforming growth factor-beta 1 (TGF beta 1) versus exogenous TGF beta 1 treatment on expression of 92-kDa type IV collagenase in mouse skin squamous cell carcinoma CH72 cells
53. Transforming growth factor-beta1 up-regulates type IV collagenase expression in cultured human keratinocytes
54. A matrix metalloproteinase expressed on the surface of invasive tumour cells
55. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-β1 in human prostate cancer cell lines
56. Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells
57. Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression
58. Type IV collagenase (Mr 72,000) expression in human prostate: Benign and malignant tissue
59. Role of interleukin 10 and transforming growth factor β1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice
60. Expression of transforming growth factor β1 in prostate cancer
61. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
62. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
63. Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue
64. Expression of transforming growth factor beta 1 (TGF-β1), -β2, and -β3 by cultured human prostatic cells
65. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: Contribution of stromal cells to their production and correlation with metastasis
66. Mesenchymal-epithelial interactions and transforming growth factor-β expression during mouse prostate morphogenesis
67. Incidence of apoptosis and cell proliferation in prostate cancer: Relationship with TGF-β1 and bcl-2 expression
68. Widely used prostate carcinoma cell lines share common origins
69. Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: Levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue
70. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes
71. ECM and cell surface proteolysis: Regulating cellular ecology
72. A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence
73. Transforming growth factor- β1 and prostate cancer
74. Proteases in prostate development, function and pathology
75. Metalloprotease activities expressed during development and maturation of the rat prostatic complex and seminal vesicles
76. Gelatinolytic and caseinolytic proteinase activities in human prostatic secretions
77. In situ hybridization studies of metalloproteinases-2 and -9 and TIMP-1 and TIMP-2 expression in human prostate cancer
78. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes